DHM VS. NAC

What NAC Is Supposed to Do

N-acetylcysteine (NAC) is a precursor to L-cysteine, which is one of the three amino acids the liver assembles into glutathione. Glutathione is your liver's main antioxidant, and ethanol metabolism depletes it as the liver works through acetaldehyde. The supplement-aisle pitch is: take NAC, your liver makes more glutathione, you have more buffer against oxidative damage from drinking.

The pitch is mechanistically reasonable. NAC is also the compound used clinically as the antidote for acetaminophen overdose, where it works for exactly this glutathione-precursor reason. So the underlying chemistry is real, and that is part of why NAC ended up in so many recovery stacks.

What the Human Trials Actually Found

The hangover-specific clinical literature on NAC is mixed at best. A 2020 randomized trial reported a modest benefit on some hangover symptoms with larger effects in women than in men¹. A separate 2024 clinical study in binge drinkers found NAC ineffective at reducing total hangover scores and made no significant difference in human markers of oxidative stress². The animal data is more positive: rats pretreated with NAC before ethanol show clear hepatoprotection and lower oxidative stress markers in liver tissue³.

The gap between animal and human results is the part to pay attention to. The mechanism works in cell culture and in rodents. It does not consistently translate to symptom reduction in actual hangovers in human volunteers, in the trials that have been run at least.

Where DHM Sits Differently

DHM is not a glutathione precursor. It does not feed into the cysteine pool, and it has no direct effect on hepatic glutathione levels through that route. What DHM does, in the published animal data, is induce ADH and ALDH directly, restore the NAD+ that ethanol metabolism depletes, and accelerate the clearance of ethanol and acetaldehyde from circulation⁴.

That difference changes the order of operations. NAC is a buffer strategy -- it assumes acetaldehyde damage is happening and tries to give cells more cleanup material. DHM is an enzyme-induction strategy -- it tries to clear acetaldehyde faster so less damage occurs to clean up. They are not the same lever pulled at the same point in the cascade. (this distinction took me weeks to internalize when I was first comparing the two ingredients side-by-side, honestly.)

Could You Combine NAC and DHM

Yes, mechanistically. A combination would give you upstream clearance acceleration plus downstream antioxidant buffering, and there is a small body of work on cysteine-plus-glutathione co-administration showing both reductions in liver damage markers and behavioral hangover improvements in mice⁵. The catch is that the dose of NAC required for any plausible hepatoprotective effect in humans is in the gram range per serving, which is well above what most stack labels include.

We built around DHM and a different glutathione-delivery approach (S-acetyl glutathione, which delivers intact GSH rather than relying on cysteine precursor synthesis) precisely because the precursor approach has translation problems in humans. The 2005 systematic review of all hangover-prevention RCTs reached a similar conclusion across the category -- most interventions show weaker effects in humans than the underlying mechanism would predict⁶.

What This Page Is Not Claiming

NAC is not a bad supplement. It has well-established clinical uses, particularly in acetaminophen overdose and in some respiratory conditions, and the safety profile is excellent. The honest statement is that for the specific use case of "blunting next-morning consequences of moderate drinking," the human clinical evidence on NAC is weaker than its mechanism suggests, adn an upstream enzyme-induction approach has more direct support in the alcohol metabolism literature.

For the upstream mechanism in detail, see How DHM Works: The ADH/ALDH Pathway. For why dose translation from animal studies to human supplement formats often goes wrong, see the under-dosing problem.